Experts from the life sciences and emerging technologies sectors converged on Fasque Castle in Aberdeenshire this week.
Speakers at the ‘Distributed Consensus‘ event included Don Tapscott, an authority on the impact of technology on business and society, who discussed the new digital relationships that will shape the future of healthcare, life sciences, and patient care.
The occasion also marked the formal launch of BioLife Chain, a bioscience project that brings together technological innovation and investment for the life sciences sector. BioLife will base its new Bioscience Technology & Research Lab at Fasque Castle, developing specialist services for the life science sector.
Guests included Yuelin Liu, chairman of China’s Belt and Road Initiative and Tinjoy Health Group, Chun Meg, deputy director-general at the Development Research Center of the State Council (DRC) in Beijing, and Shao Luping, chairman of the Leukerbad Rejuvenation Industry Group.
BioLife will develop the most immediate opportunities in the sector, making cutting-edge bioscience technologies available for wealthy and globally mobile patients – Genevieve Leveille.
As a leading life and biosciences cluster, Scotland was selected as the preferred international site for BioLife, “providing the ideal environment for innovation, access to leading-edge industry partners, and talent,” said a spokesperson. The country’s reputation for its digital health record system represents a key area of interest for BioLife with its aim to meet the high demand for personal health data that entails precise treatment and targeted therapy based on gene decoding.
“BioLife will develop the most immediate opportunities in the sector, making cutting-edge bioscience technologies available for wealthy and globally mobile patients, initially in Scotland and Switzerland, with other strategic locations to follow,” said Genevieve Leveille, BioLife’s venture and technology partner.
“In a healthcare future that is increasingly preventative, personalised and precise, patients need to be able to access the best care and self-manage their health. We will be creating an electronic health record as a service (“EHRaaS”) and global marketplace for the digitisation and monetisation of bioscience assets.”
Tapscott, co-founder and executive chairman of the Blockchain Research Institute and author of The Blockchain Revolution, commented: “I believe BioLife will help shape the future of healthcare, empowering patients and creating new industry collaborations that will advance research and development in life sciences.
“Blockchain technology is all about enabling digital relationships, and BioLife will provide a valuable example and use-case in the life science sector.”
The BioLife Distributed Consensus event took place on Tuesday and Wednesday this week. Organisers said BioLife’s Blockchain & Research Lab will help bring new investment to Scotland’s life sciences sector and establish Fasque Castle as an international health tourism destination.
